EPCLUSA
Analogs of EPCLUSA
Find cheaper analogs and generic equivalents for EPCLUSA.
Active Ingredient: SOFOSBUVIR, VELPATASVIR
Product Overview
About EPCLUSA
EPCLUSA is a prescription medication containing the active ingredients Sofosbuvir and Velpatasvir. It is used to treat chronic hepatitis C virus (HCV) infection in adults with or without cirrhosis, including those with a history of liver transplantation.
Key Benefits & Uses
- Treatment of chronic hepatitis C virus (HCV) infection in adults with or without cirrhosis
- Treatment of HCV infection in adults with a history of liver transplantation
- Combination therapy with other medications to achieve sustained virologic response (SVR) in patients with HCV genotype 1, 2, 3, 4, 5, or 6
Active Ingredient & Action
Sofosbuvir is a nucleotide analog inhibitor that works by blocking the replication of the HCV virus. Velpatasvir is a non-nucleoside inhibitor that targets the NS5A protein of the HCV virus, preventing the virus from replicating. The combination of Sofosbuvir and Velpatasvir in EPCLUSA provides a synergistic effect, increasing the likelihood of achieving SVR in patients with HCV infection.
Important Notes
EPCLUSA is available in tablet form and should be taken orally once daily with or without food. It is essential to complete the full treatment course as prescribed by your healthcare provider to achieve optimal results. Inform your healthcare provider of any medical history, including liver disease, kidney disease, or other health conditions, before starting treatment with EPCLUSA.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.
